Clincosm LogoSign in Get a demo

Lymphoma, B-Cell, Marginal Zone

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia, Lymphoid, Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell Trial in China (LOXO-305)

Active, not recruiting
  • Leukemia, Lymphoid
  • +6 more
  • Wuhu, Anhui, China
  • +22 more
Dec 8, 2022

Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse Trial in Spain (Registry of

Recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • Registry of patients (exposure is Cutaneous Lymphoma)
  • Barcelona, Spain
  • +13 more
Mar 15, 2022

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Mantle-Cell Trial in Providence (Rituximab, Bendamustine, Vincristine

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • +5 more
  • Providence, Rhode Island
    Rhode Island Hospital and The Miriam Hospital
Jul 19, 2021

Lymphoma, B-Cell, Marginal Zone Trial in Seoul, Singapore (Ibrutinib)

Unknown status
  • Lymphoma, B-Cell, Marginal Zone
  • Seoul, Korea, Republic of
  • +2 more
Sep 12, 2018

Lymphoma, B-Cell, Marginal Zone Trial in Busan (Rituximab)

Unknown status
  • Lymphoma, B-Cell, Marginal Zone
  • Rituximab
  • Busan, Korea, Republic of
    Sung Yong Oh
Apr 17, 2018

Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone Trial (Ofatumumab)

Withdrawn
  • Lymphoma, Non-Hodgkin
  • +4 more
  • (no location specified)
Oct 8, 2015